 MENLO PARK, Calif., Feb. 09, 2021 GLOBE NEWSWIRE -- CohBar, Inc. NASDAQ: CWBR, a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, will present a company overview at the BIO CEO Investor Digital Conference, being held virtually on February 16 - 18, 2021. This presentation will be available on demand for registered attendees. 